Some applications of the present invention relate in general to cardiac repair. More specifically, some applications of the present invention relate to facilitating implantation of artificial chordae tendineae.
Ischemic heart disease can cause mitral regurgitation by the combination of ischemic dysfunction of the papillary muscles, and the dilatation of the left ventricle that is present in ischemic heart disease, with the subsequent displacement of the papillary muscles and the dilatation of the mitral valve annulus.
Dilation of the annulus of the mitral valve can prevent the valve leaflets from fully coapting when the valve is closed. Mitral regurgitation of blood from the left ventricle into the left atrium can result in increased total stroke volume and decreased cardiac output, and ultimate weakening of the left ventricle secondary to a volume overload and a pressure overload of the left atrium.
Chronic or acute left ventricular dilatation can lead to papillary muscle displacement with increased leaflet tethering due to tension on chordae tendineae, as well as annular dilatation.
Techniques are provided for determining an appropriate chord-length for an artificial chorda tendinea by placing markers, such as radiopaque markers, against tissue sites within the heart, and calculating (e.g., measuring, calculating using a computer program, etc.) a distance between the markers. Typically, one marker is placed against a papillary muscle, and another marker is placed against one or more leaflets, and the chord-length is based on the calculated or measured distance between these markers. The artificial chorda tendinea can then be implanted.
The determination of the chord-length and the implantation of the artificial chorda tendinea are typically performed percutaneously, e.g., transluminally (i.e., via a blood vessel), such as transfemorally, transseptally, etc. Therefore, the techniques described herein can be performed without line-of-sight or direct visualization, but instead can be facilitated by imaging technologies such as echocardiography and fluoroscopy.
There is therefore provided, in an exemplary application, a method for use in a heart (e.g., for use with a native valve of a heart of a subject). The method includes percutaneously advancing a first radiopaque marker and a second radiopaque marker to the heart. The method also includes placing the first radiopaque marker against a first tissue site in the heart (e.g., the ventricle) and placing the second radiopaque marker at a second tissue site in the heart (e.g., at or proximate a valve of the heart, such as an atrioventricular valve, etc.). The method also includes calculating and/or measuring a distance between the first radiopaque marker at the first tissue site, and the second radiopaque marker at the second tissue site, and responsively to the distance (i.e., the distance calculated or measured), determining a tether-length.
Placing the second radiopaque marker against the leaflet can include placing the second radiopaque marker against a free edge of the leaflet. Placing the first radiopaque marker against the first tissue site can include anchoring, to the first tissue site, an anchor that includes the first radiopaque marker. Placing the first radiopaque marker against the first tissue site can include placing the first radiopaque marker against the first tissue site under echocardiographic guidance. Placing the second radiopaque marker against the second tissue site can include placing the second radiopaque marker against the second tissue site under echocardiographic guidance.
Calculating or measuring the distance can include measuring the distance using fluoroscopy and/or on a fluoroscopic image. Calculating or measuring the distance can include using a computer program or software to measure and/or estimate the distance between markers. The computer program or software can use image recognition and/or other tools, sensors, inputs, etc. to measure and/or estimate the distance between markers.
Advancing the first and second radiopaque markers can include advancing the first and second radiopaque markers transluminally (e.g., transfemorally, transseptally, etc.).
The second tissue site can be a first leaflet of a valve of the heart, and placing the first radiopaque marker against the second tissue site can include placing the first radiopaque marker at a systolic coaptation level between the first leaflet and a second leaflet of the valve.
The first tissue site can be on a papillary muscle, and placing the first radiopaque marker against the first tissue site can include placing the first radiopaque marker against the papillary muscle.
The method can further include selecting the tether based on and/or having the tether-length from a selection of tethers that includes at least one tether that does not have the tether-length (e.g., being longer than the tether-length). The method can include adjusting the tether to the tether-length. For example, the method can include trimming the tether to the tether-length.
The method can further include implanting, in the heart, a tether selected based on and/or having the tether-length.
Implanting the tether can include attaching a first end portion of the tether to the tissue site and attaching a second end portion of the tether to the second tissue site.
The method can also include additional steps described elsewhere in this disclosure.
In an exemplary application, a method for use with a native valve of a heart of a subject (the valve can be disposed between an atrium and a ventricle of the heart) the method including:
percutaneously advancing a first radiopaque marker and a second radiopaque marker to the heart;
placing the first radiopaque marker against a tissue site in the ventricle;
placing the second radiopaque marker against a leaflet of the valve;
calculating or measuring a distance between the first radiopaque marker at the tissue site, and the second radiopaque marker at the leaflet; and
responsively to the distance (i.e., the calculated or measured distance), determining a chord-length.
In an application, placing the first radiopaque marker against the tissue site includes anchoring, to the tissue site, a tissue anchor that includes the first radiopaque marker.
In an application, placing the first radiopaque marker against the tissue site includes placing the first radiopaque marker against the tissue site under echocardiographic guidance.
In an application, placing the second radiopaque marker against the leaflet includes placing the first radiopaque marker against the leaflet under echocardiographic guidance.
In an application, calculating or measuring the distance includes measuring the distance using fluoroscopy and/or measuring the distance on a fluoroscopic image. Calculating or measuring the distance can include using a computer program or software to measure and/or estimate the distance between markers. The computer program or software can use image recognition and/or other tools, sensors, inputs, etc. to measure and/or estimate the distance between markers.
In an application, advancing the first and second radiopaque markers includes advancing the first and second radiopaque markers transluminally.
In an application, the leaflet is a first leaflet, and placing the first radiopaque marker against the leaflet includes placing the first radiopaque marker at a systolic coaptation level between the first leaflet and a second leaflet of the valve.
In an application, the tissue site is on a papillary muscle, and placing the first radiopaque marker against the tissue site includes placing the first radiopaque marker against the papillary muscle.
In an application, the method further includes selecting the artificial chord based on and/or having the chord-length from a selection of chords that includes at least one chord that does not have the chord-length.
In an application, the method further includes adjusting the artificial chord to the chord-length.
In an application, the method further includes trimming the artificial chord to the chord-length.
The method can further include implanting, in the heart, an artificial chord based on and/or having the chord-length.
In an application, implanting the artificial chord includes attaching a first end portion of the artificial chord to the tissue site and attaching a second end portion of the artificial chord to the leaflet.
In an application:
the leaflet is a first leaflet,
the artificial chord is a first artificial chord,
implanting the artificial chord includes attaching a first end portion of the first artificial chord to the tissue site and attaching a second end portion of the first artificial chord to the leaflet, and
the method further includes implanting a second artificial chord by attaching a second end portion of the second artificial chord to a second leaflet of the native valve.
In an application, implanting the second artificial chord includes attaching a first end portion of the second artificial chord to a second tissue site in the ventricle.
In an application, the first radiopaque marker is disposed on a first elongate tool, and placing the first radiopaque marker against the tissue site includes placing the first tool against the tissue site.
In an application, the first tool is shaped to define a lumen therethrough, and the method further includes advancing the artificial chord to the heart within the lumen.
In an application, implanting the artificial chord includes anchoring a first end portion of the artificial chord to the tissue site without removing the first tool from the tissue site.
In an application, implanting the artificial chord includes anchoring a tissue anchor to the tissue site without removing the first tool from the tissue site.
In an application, a first end portion of the artificial chord is attached to the tissue anchor, and anchoring the tissue anchor to the tissue site includes anchoring the first end portion of the artificial chord to the tissue site.
In an application, an elongate guide member is coupled to the tissue anchor, and anchoring the tissue anchor to the tissue site includes anchoring the guide member to the tissue site.
In an application, implanting the artificial chord includes, subsequently to anchoring the tissue anchor, advancing the artificial chord along the guide member to the tissue anchor and coupling the artificial chord to the tissue anchor.
In an application, the method further includes, subsequently to anchoring the tissue anchor, removing the first tool from the tissue site and the tissue anchor, and advancing the artificial chord along the guide member to the tissue anchor includes advancing the artificial chord along the guide member to the tissue anchor subsequently to removing the first tool from the tissue site and the tissue anchor.
In an application, the method further includes, subsequently to coupling the artificial chord to the tissue anchor, decoupling the guide member from the tissue anchor.
In an application, the first radiopaque marker is disposed on a distal end of the first tool, and placing the first radiopaque marker against the tissue site includes placing the distal end of the first tool against the tissue site.
In an application, the first radiopaque marker is disposed on a first elongate tool, the second radiopaque marker is disposed on a second elongate tool that is slidably coupled to the first tool, and:
advancing the first radiopaque marker and the second radiopaque marker to the heart includes advancing the first tool and the second tool to the heart, and
the method further includes sliding the second tool with respect to the first tool in order to place at least one radiopaque marker selected from the group consisting of: the first radiopaque marker and the second radiopaque marker.
In an application:
the second tool includes a longitudinal shaft and an appendage,
the second radiopaque marker is disposed on the appendage,
the method further includes extending the appendage laterally from the longitudinal shaft, and
placing the second radiopaque marker against the leaflet includes moving the second tool until the appendage abuts the leaflet.
In an application, the first tool is slidable within the second tool, and sliding the second tool with respect to the first tool includes sliding the first tool within the second tool.
There is further provided, in an exemplary application, a method, including:
advancing a first marker (e.g., a first radiopaque marker) and a second marker (e.g., a second radiopaque marker) along a simulated vasculature to a simulated heart, the heart having a simulated valve disposed between a simulated atrium and a simulated ventricle;
placing the first marker against a simulated tissue site in the ventricle;
placing the second marker against a simulated leaflet of the valve;
calculating or measuring a distance between the first marker at the tissue site, and the second marker at the leaflet; and
responsively to the distance, determining a chord-length.
The simulated vasculature can be a computer-simulated vasculature, the simulated heart can be a computer-simulated heart, and the step of advancing can include advancing the first marker and the second marker along the computer-simulated vasculature to the computer-simulated heart.
The simulated vasculature can be a physical model of vasculature, the simulated heart can be a physical model of a heart, and the step of advancing can include advancing the first marker and the second marker along the physical model of the vasculature to the physical model of the heart.
The markers can be radiopaque markers, computer-simulated markers, or computer-simulated radiopaque markers.
In an application, calculating or measuring the distance includes measuring the distance using fluoroscopy and/or measuring the distance on a fluoroscopic image. Calculating or measuring the distance can include using a computer program or software to measure and/or estimate the distance between markers. The computer program or software can use image recognition and/or other tools, sensors, inputs, etc. to measure and/or estimate the distance between markers.
In some applications, the first marker is a first computer-simulated radiopaque marker and the second marker is a second computer-simulated radiopaque marker, and calculating the distance comprises measuring the distance between the first computer-simulated radiopaque marker and the second computer-simulated radiopaque marker on a computer-simulated fluoroscopic image.
The simulated heart can be a simulation of a heart of a particular human subject, and the method can be a method for planning a chord-implantation procedure on the particular human subject.
In an application, placing the first marker against the tissue site includes anchoring, to the tissue site, a tissue anchor that includes the first marker.
In an application, placing the first marker against the tissue site includes placing the first marker against the tissue site under echocardiographic guidance.
In an application, placing the second marker against the leaflet includes placing the first marker against the leaflet under echocardiographic guidance.
The echocardiographic guidance can use actual ultrasound, or can be computer-simulated.
In an application, calculating or measuring the distance includes measuring the distance using fluoroscopy.
The fluoroscopy can be actual fluoroscopy, or can be computer-simulated fluoroscopy.
In an application, the leaflet is a first simulated leaflet, and placing the first marker against the leaflet includes placing the first marker at a coaptation level between the first leaflet and a second simulated leaflet of the valve.
In an application, the tissue site is on a simulated papillary muscle, and placing the first marker against the tissue site includes placing the first marker against the papillary muscle.
In an application, the method further includes selecting the artificial chord based on the chord-length from a selection of chords that includes at least one chord that does not have the chord-length.
In an application, the method further includes adjusting the artificial chord to the chord-length.
In an application, the method further includes trimming the artificial chord to the chord-length.
In an application, the method further includes implanting, in the heart, an artificial chord selected based on the chord-length.
In an application, implanting the artificial chord includes attaching a first end portion of the artificial chord to the tissue site and attaching a second end portion of the artificial chord to the leaflet.
In an application:
the leaflet is a first simulated leaflet,
the artificial chord is a first artificial chord,
implanting the artificial chord includes attaching a first end portion of the first artificial chord to the tissue site and attaching a second end portion of the first artificial chord to the first simulated leaflet, and
the method further includes implanting a second artificial chord by attaching a second end portion of the second artificial chord to a second simulated leaflet of the simulated valve.
In an application, implanting the second artificial chord includes attaching a first end portion of the second artificial chord to a second simulated tissue site in the ventricle.
In an application, the first marker is disposed on a first elongate tool, and placing the first marker against the tissue site includes placing the first tool against the tissue site.
In an application, the first tool is shaped to define a lumen therethrough, and the method further includes advancing the artificial chord to the heart within the lumen.
In an application, implanting the artificial chord includes anchoring a first end portion of the artificial chord to the tissue site without removing the first tool from the tissue site.
In an application, implanting the artificial chord includes anchoring a tissue anchor to the tissue site without removing the first tool from the tissue site.
In an application, a first end portion of the artificial chord is attached to the tissue anchor, and anchoring the tissue anchor to the tissue site includes anchoring the first end portion of the artificial chord to the tissue site.
In an application, an elongate guide member is coupled to the tissue anchor, and anchoring the tissue anchor to the tissue site includes anchoring the guide member to the tissue site.
In an application, implanting the artificial chord includes, subsequently to anchoring the tissue anchor, advancing the artificial chord along the guide member to the tissue anchor and coupling the artificial chord to the tissue anchor.
In an application, the method further includes, subsequently to anchoring the tissue anchor, removing the first tool from the tissue site and the tissue anchor, and advancing the artificial chord along the guide member to the tissue anchor includes advancing the artificial chord along the guide member to the tissue anchor subsequently to removing the first tool from the tissue site and the tissue anchor.
In an application, the method further includes, subsequently to coupling the artificial chord to the tissue anchor, decoupling the guide member from the tissue anchor.
In an application, the first marker is disposed on a distal end of the first tool, and placing the first marker against the tissue site includes placing the distal end of the first tool against the tissue site.
In an application, the first marker is disposed on a first elongate tool, the second marker is disposed on a second elongate tool that is slidably coupled to the first tool, and:
advancing the first marker and the second marker to the heart includes advancing the first tool and the second tool to the heart, and
the method further includes sliding the second tool with respect to the first tool in order to place at least one radiopaque marker selected from the group consisting of: the first marker and the second marker.
In an application:
the second tool includes a longitudinal shaft and an appendage,
the second marker is disposed on the appendage,
the method further includes extending the appendage laterally from the longitudinal shaft, and
placing the second marker against the leaflet includes moving the second tool until the appendage abuts the leaflet.
In an application, the first tool is slidable within the second tool, and sliding the second tool with respect to the first tool includes sliding the first tool within the second tool.
There is further provided, in accordance with an application of the present invention, a method, including:
advancing a first marker (e.g., first radiopaque marker) and a second marker (e.g., second radiopaque marker) along a simulated vasculature to a simulated heart, the heart having a simulated valve disposed between a simulated atrium and a simulated ventricle;
placing the first marker against a first simulated tissue site in the ventricle;
placing the second marker at a second simulated tissue site at or proximate the valve;
calculating or measuring a distance between the first marker at the first tissue site, and the second marker at the second tissue site; and
responsively to the distance, determining a tether-length.
In an application:
the simulated vasculature is a computer-simulated vasculature, and the simulated heart is a computer-simulated heart; and
the step of advancing includes advancing the first marker and the second marker along the computer-simulated vasculature to the computer-simulated heart.
In an application:
the simulated vasculature is a physical model of vasculature, and the simulated heart is a physical model of a heart; and
the step of advancing includes advancing the first marker and the second marker along the physical model of the vasculature to the physical model of the heart.
In an application:
the simulated heart is a simulation of a heart of a particular human subject, and
the method is a method for planning a tether-implantation procedure on the particular human subject.
In an application, placing the first marker against the first tissue site includes anchoring, to the first tissue site, an anchor that includes the first marker.
In an application, placing the first marker against the first tissue site includes placing the first marker against the first tissue site under echocardiographic guidance.
In an application, placing the second marker against the second tissue site includes placing the second marker against the second tissue site under echocardiographic guidance.
In an application, calculating or measuring the distance includes measuring the distance using fluoroscopy and/or measuring the distance on a fluoroscopic image. Calculating or measuring the distance can include using a computer program or software to measure and/or estimate the distance between markers. The computer program or software can use image recognition and/or other tools, sensors, inputs, etc. to measure and/or estimate the distance between markers.
In an application, the second tissue site is a first simulated leaflet, and placing the first marker against the second tissue site includes placing the first marker at a systolic coaptation level between the first leaflet and a second simulated leaflet of the valve.
In an application, the first tissue site is on a simulated papillary muscle, and placing the first marker against the first tissue site includes placing the first marker against the papillary muscle.
In an application, the method further includes selecting the tether based on the tether-length from a selection of tethers that includes at least one tether that does not have the tether-length.
In an application, the method further includes adjusting the tether to the tether-length.
In an application, the method further includes trimming the tether to the tether-length.
In an application, the method further includes implanting, in the heart, a tether selected based on the tether-length.
In an application, implanting the tether includes attaching a first end portion of the tether to the tissue site and attaching a second end portion of the tether to the second tissue site.
The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:
Reference is made to
A first marker or first radiopaque marker 32 and a second marker or a second radiopaque marker 34 are advanced to the heart. Marker 32 can be disposed on (e.g., at a distal end of) a first tool 22. Marker 34 can be disposed on (e.g., at a distal end of) a second tool 24. It is to be noted that, in this context, the terms “first” and “second” are used purely to distinguish each marker from the other, and each tool from the other, and are not intended to specify an order in which these elements are arranged or used.
First marker 32 is placed against a tissue site 42 in ventricle 8 (
For some applications, and as shown, tissue site 42 is on a papillary muscle 12 of the heart. For some applications, tissue site 42 is on a ventricular wall (e.g., inner wall, septum, outer wall, etc.) of the heart.
For some applications, second marker 34 is placed against a tissue site 44 in the atrium, ventricle, or between, e.g., on one or multiple leaflets 14 of valve 10 (
For some applications, tool 22 is slidably coupled to tool 24, the operator slides the tools with respect to each other in order to place markers 32 and 34 against their corresponding tissue sites. For example, tool 22 can be slidable within tool 24 (e.g., coaxially, as shown), or tool 24 can be slidable within tool 22. Tools 22 and 24 could also be slidable or otherwise movable adjacent to each other without necessarily being coaxial or one inside the other.
For some applications, second tool 24 includes a longitudinal shaft 26 and marker 34 is disposed on the longitudinal shaft. For some applications, and as shown in
For some applications, appendage 28 is self-expanding, and is transitioned into its expanded state by exposing it from sheath 26. For example, appendage 28 can comprise an elastic and/or shape memory material such as Nitinol. For some applications, appendage 28 has a stent structure. For some applications, appendage 28 has a braid structure. For some applications, appendage 28 is mechanically expanded, e.g., using an actuator. For some applications, appendage 28 is expanded using a balloon.
For some applications, one or more imaging techniques (e.g., echocardiographic and/or fluoroscopic guidance) are used to facilitate placement of marker 32 and/or marker 34. For example, although for some applications abutment of appendage 28 against leaflets 14 can be detected via tactile feedback, this can be alternatively or additionally determined using one or more imaging techniques.
A distance d1 can be calculated or measured between the marker 32 at tissue site 42, and marker 34 at tissue site 44. The distance can be measured by observing markers 32 and 42 using fluoroscopy (e.g., determining d1 from measurement of the distance between markers on a fluoroscopy image), and/or by judging the relative insertion distance of tools 22 and 24 (e.g., a proximal end remaining outside the body can include markings or gradations to show relative distance between the tools and their markers when the markers are positioned as desired). It is hypothesized by the inventor that fluoroscopy provides a more accurate indication and/or measurement of distance d1 than do other techniques, such as echocardiography.
Responsively to measured distance d1, an appropriate chord-length is determined for an artificial chord (i.e., an artificial chorda tendinea) or other tether or line to be implanted in the heart. For some applications, the chord/tether-length can be equal to distance d1. For some applications, the chord/tether-length can be greater than distance d1. For some applications, the chord/tether-length can be smaller than distance d1.
An artificial chord 60 or other tether/line (discussion of chord 60 also applies to other tethers/lines that can serve other functions and/or be positioned differently from an artificial chorda tendinea), having the determined chord/tether-length, is subsequently implanted in the heart. For some applications, chord/tether 60 is selected from a selection of chords/tethers that includes at least one chord/tether that does not have the determined chord/tether-length. For some applications, chord/tether 60 is adjusted to the determined chord/tether-length. For some applications, chord/tether 60 is trimmed to the determined chord/tether-length.
For some applications, tool 22 is shaped to define a lumen therethrough, and chord/tether 60 is advanced to the heart within the lumen. For such applications, the attachment of the first end portion of chord/tether 60 to tissue site 42 is typically performed without removing tool 22 from the tissue site. That is, for such applications, tool 22 can remain at the same tissue site 42 as when distance d1 was measured, at least until the first end portion of chord/tether 60 is attached to tissue site 42.
For some applications, and as shown, a tissue anchor 62 is attached to tissue site 42 in order to facilitate attachment of chord/tether 60 to the tissue site. However, other types of attachment means can be used, e.g., clips, sutures, adhesives, knots, pledgets, staples, other anchors, etc.
For some applications in which tissue anchor 62 is used, the first end portion of chord/tether 60 is attached to the tissue anchor (i.e., the chord/tether is provided with the anchor pre-attached), and anchoring the tissue anchor to tissue site 42 anchors the first end portion of chord to the tissue site.
Reference is now made to
For some applications, coupling of chord/tether 60 to tissue anchor 62 can be implemented using attachment means herein or technology described, mutatis mutandis, in one or more of the following publications, which are incorporated herein by reference:
Reference is now made to
Reference is again made to
Reference is again made to
Reference is again made to
Components, aspects, features, etc. of the systems, apparatuses, devices, methods, etc. described herein can be implemented in hardware, software, or a combination of both. Where components, aspects, features, etc. of the systems, devices, methods, etc. described herein are implemented in software, the software can be stored in an executable format on one or more non-transitory machine-readable mediums. Further, the software and related steps of the methods described above can be implemented in software as a set of data and instructions. Information representing the apparatuses, units, systems, and/or methods stored on the machine-readable medium can be used in the process of creating the apparatuses, units, systems, and/or methods described herein. Hardware used to implement the invention can include integrated circuits, microprocessors, FPGAs, digital signal controllers, stream processors, and/or other components.
The present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features and steps described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
The present application is a continuation from Patent Cooperation Treaty Application No. PCT/IL2019/050083 to Reich, filed on Jan. 22, 2019, published as WO 2019/145941, which claims priority from U.S. Provisional Patent Application 62/622,315 to Reich, filed Jan. 26, 2018, each of which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3604488 | Wishart et al. | Sep 1971 | A |
3656185 | Carpentier | Apr 1972 | A |
3840018 | Heifetz | Oct 1974 | A |
3881366 | Bradley et al. | May 1975 | A |
3898701 | La Russa | Aug 1975 | A |
4042979 | Angell | Aug 1977 | A |
4118805 | Reimels | Oct 1978 | A |
4214349 | Munch | Jul 1980 | A |
4261342 | Aranguren Duo | Apr 1981 | A |
4290151 | Massana | Sep 1981 | A |
4434828 | Trincia | Mar 1984 | A |
4473928 | Johnson | Oct 1984 | A |
4602911 | Ahmadi et al. | Jul 1986 | A |
4625727 | Leiboff | Dec 1986 | A |
4712549 | Peters et al. | Dec 1987 | A |
4778468 | Hunt | Oct 1988 | A |
4917698 | Carpentier et al. | Apr 1990 | A |
4935027 | Yoon | Jun 1990 | A |
4961738 | Mackin | Oct 1990 | A |
5042707 | Taheri | Aug 1991 | A |
5061277 | Carpentier et al. | Oct 1991 | A |
5064431 | Gilbertson et al. | Nov 1991 | A |
5104407 | Lam et al. | Apr 1992 | A |
5108420 | Marks | Apr 1992 | A |
5201880 | Wright et al. | Apr 1993 | A |
5258008 | Wilk | Nov 1993 | A |
5300034 | Behnke et al. | Apr 1994 | A |
5325845 | Adair | Jul 1994 | A |
5346498 | Greelis et al. | Sep 1994 | A |
5383852 | Stevens-Wright | Jan 1995 | A |
5449368 | Kuzmak | Sep 1995 | A |
5450860 | O'Connor | Sep 1995 | A |
5464404 | Abela et al. | Nov 1995 | A |
5474518 | Farrer Velazquez | Dec 1995 | A |
5477856 | Lundquist | Dec 1995 | A |
5593424 | Northrup, III | Jan 1997 | A |
5601572 | Middleman et al. | Feb 1997 | A |
5626609 | Zvenyatsky et al. | May 1997 | A |
5643317 | Pavcnik et al. | Jul 1997 | A |
5669919 | Sanders et al. | Sep 1997 | A |
5676653 | Taylor et al. | Oct 1997 | A |
5683402 | Cosgrove et al. | Nov 1997 | A |
5702397 | Goble et al. | Dec 1997 | A |
5702398 | Tarabishy | Dec 1997 | A |
5709695 | Northrup, III | Jan 1998 | A |
5716370 | Williamson, IV et al. | Feb 1998 | A |
5716397 | Myers | Feb 1998 | A |
5728116 | Rosenman | Mar 1998 | A |
5730150 | Peppel et al. | Mar 1998 | A |
5749371 | Zadini et al. | May 1998 | A |
5752963 | Allard et al. | May 1998 | A |
5782844 | Yoon et al. | Jul 1998 | A |
5810882 | Bolduc et al. | Sep 1998 | A |
5824066 | Gross | Oct 1998 | A |
5830221 | Stein et al. | Nov 1998 | A |
5843120 | Israel et al. | Dec 1998 | A |
5855614 | Stevens et al. | Jan 1999 | A |
5860923 | Lenker et al. | Jan 1999 | A |
5876373 | Giba et al. | Mar 1999 | A |
5935098 | Blaisdell et al. | Aug 1999 | A |
5957953 | DiPoto et al. | Sep 1999 | A |
5961440 | Schweich, Jr. et al. | Oct 1999 | A |
5961539 | Northrup, III et al. | Oct 1999 | A |
5984959 | Robertson et al. | Nov 1999 | A |
5993459 | Larsen et al. | Nov 1999 | A |
6042554 | Rosenman et al. | Mar 2000 | A |
6045497 | Schweich, Jr. et al. | Apr 2000 | A |
6050936 | Schweich, Jr. et al. | Apr 2000 | A |
6059715 | Schweich, Jr. et al. | May 2000 | A |
6074341 | Anderson et al. | Jun 2000 | A |
6074401 | Gardiner et al. | Jun 2000 | A |
6074417 | Peredo | Jun 2000 | A |
6086582 | Altman et al. | Jul 2000 | A |
6102945 | Campbell | Aug 2000 | A |
6106550 | Magovern et al. | Aug 2000 | A |
6110200 | Hinnenkamp | Aug 2000 | A |
6132390 | Cookston et al. | Oct 2000 | A |
6143024 | Campbell et al. | Nov 2000 | A |
6159240 | Sparer et al. | Dec 2000 | A |
6165119 | Schweich, Jr. et al. | Dec 2000 | A |
6174332 | Loch et al. | Jan 2001 | B1 |
6183411 | Mortier et al. | Feb 2001 | B1 |
6187040 | Wright | Feb 2001 | B1 |
6210347 | Forsell | Apr 2001 | B1 |
6217610 | Carpentier et al. | Apr 2001 | B1 |
6228032 | Eaton et al. | May 2001 | B1 |
6231602 | Carpentier et al. | May 2001 | B1 |
6251092 | Qin et al. | Jun 2001 | B1 |
6296656 | Bolduc et al. | Oct 2001 | B1 |
6315784 | Djurovic | Nov 2001 | B1 |
6319281 | Patel | Nov 2001 | B1 |
6328746 | Gambale | Dec 2001 | B1 |
6332893 | Mortier et al. | Dec 2001 | B1 |
6355030 | Aldrich et al. | Mar 2002 | B1 |
6361559 | Houser et al. | Mar 2002 | B1 |
6368348 | Gabbay | Apr 2002 | B1 |
6402780 | Williamson, IV et al. | Jun 2002 | B2 |
6406420 | McCarthy et al. | Jun 2002 | B1 |
6406493 | Tu et al. | Jun 2002 | B1 |
6419696 | Ortiz et al. | Jul 2002 | B1 |
6451054 | Stevens | Sep 2002 | B1 |
6458076 | Pruitt | Oct 2002 | B1 |
6461336 | Larre | Oct 2002 | B1 |
6461366 | Seguin | Oct 2002 | B1 |
6470892 | Forsell | Oct 2002 | B1 |
6503274 | Howanec, Jr. et al. | Jan 2003 | B1 |
6524338 | Gundry | Feb 2003 | B1 |
6527780 | Wallace et al. | Mar 2003 | B1 |
6530952 | Vesely | Mar 2003 | B2 |
6533772 | Sherts et al. | Mar 2003 | B1 |
6537314 | Langberg et al. | Mar 2003 | B2 |
6547801 | Dargent et al. | Apr 2003 | B1 |
6554845 | Fleenor et al. | Apr 2003 | B1 |
6564805 | Garrison et al. | May 2003 | B2 |
6565603 | Cox | May 2003 | B2 |
6569198 | Wilson et al. | May 2003 | B1 |
6579297 | Bicek et al. | Jun 2003 | B2 |
6589160 | Schweich, Jr. et al. | Jul 2003 | B2 |
6592593 | Parodi et al. | Jul 2003 | B1 |
6602288 | Cosgrove et al. | Aug 2003 | B1 |
6602289 | Colvin et al. | Aug 2003 | B1 |
6613078 | Barone | Sep 2003 | B1 |
6613079 | Wolinsky et al. | Sep 2003 | B1 |
6619291 | Hlavka et al. | Sep 2003 | B2 |
6626899 | Houser et al. | Sep 2003 | B2 |
6626917 | Craig | Sep 2003 | B1 |
6626930 | Allen et al. | Sep 2003 | B1 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6629921 | Schweich, Jr. et al. | Oct 2003 | B1 |
6651671 | Donlon et al. | Nov 2003 | B1 |
6652556 | VanTassel et al. | Nov 2003 | B1 |
6682558 | Tu et al. | Jan 2004 | B2 |
6689125 | Keith et al. | Feb 2004 | B1 |
6689164 | Seguin | Feb 2004 | B1 |
6695866 | Kuehn et al. | Feb 2004 | B1 |
6702826 | Liddicoat et al. | Mar 2004 | B2 |
6702846 | Mikus et al. | Mar 2004 | B2 |
6706065 | Langberg et al. | Mar 2004 | B2 |
6709385 | Forsell | Mar 2004 | B2 |
6709456 | Langberg et al. | Mar 2004 | B2 |
6711444 | Koblish | Mar 2004 | B2 |
6719786 | Ryan et al. | Apr 2004 | B2 |
6723038 | Schroeder et al. | Apr 2004 | B1 |
6726716 | Marquez | Apr 2004 | B2 |
6726717 | Alfieri et al. | Apr 2004 | B2 |
6749630 | McCarthy et al. | Jun 2004 | B2 |
6752813 | Goldfarb et al. | Jun 2004 | B2 |
6764310 | Ichihashi et al. | Jul 2004 | B1 |
6764510 | Vidlund et al. | Jul 2004 | B2 |
6764810 | Ma et al. | Jul 2004 | B2 |
6770083 | Seguin | Aug 2004 | B2 |
6786924 | Ryan et al. | Sep 2004 | B2 |
6786925 | Schoon et al. | Sep 2004 | B1 |
6790231 | Liddicoat et al. | Sep 2004 | B2 |
6797001 | Mathis et al. | Sep 2004 | B2 |
6797002 | Spence et al. | Sep 2004 | B2 |
6802319 | Stevens et al. | Oct 2004 | B2 |
6805710 | Bolling et al. | Oct 2004 | B2 |
6805711 | Quijano et al. | Oct 2004 | B2 |
6855126 | Flinchbaugh | Feb 2005 | B2 |
6858039 | McCarthy | Feb 2005 | B2 |
6884250 | Monassevitch et al. | Apr 2005 | B2 |
6893459 | Macoviak | May 2005 | B1 |
6908478 | Alferness et al. | Jun 2005 | B2 |
6908482 | McCarthy et al. | Jun 2005 | B2 |
6918917 | Nguyen et al. | Jul 2005 | B1 |
6926730 | Nguyen et al. | Aug 2005 | B1 |
6960217 | Bolduc | Nov 2005 | B2 |
6976995 | Mathis et al. | Dec 2005 | B2 |
6986775 | Morales et al. | Jan 2006 | B2 |
6989028 | Lashinski et al. | Jan 2006 | B2 |
6997951 | Solem et al. | Feb 2006 | B2 |
7004176 | Lau | Feb 2006 | B2 |
7007798 | Happonen et al. | Mar 2006 | B2 |
7011669 | Kimblad | Mar 2006 | B2 |
7011682 | Lashinski et al. | Mar 2006 | B2 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7037334 | Hlavka et al. | May 2006 | B1 |
7077850 | Kortenbach | Jul 2006 | B2 |
7077862 | Vidlund et al. | Jul 2006 | B2 |
7087064 | Hyde | Aug 2006 | B1 |
7101395 | Tremulis et al. | Sep 2006 | B2 |
7101396 | Artof et al. | Sep 2006 | B2 |
7112207 | Allen et al. | Sep 2006 | B2 |
7118595 | Ryan et al. | Oct 2006 | B2 |
7125421 | Tremulis et al. | Oct 2006 | B2 |
7150737 | Purdy et al. | Dec 2006 | B2 |
7159593 | McCarthy et al. | Jan 2007 | B2 |
7166127 | Spence et al. | Jan 2007 | B2 |
7169187 | Datta et al. | Jan 2007 | B2 |
7172625 | Shu et al. | Feb 2007 | B2 |
7175660 | Cartledge et al. | Feb 2007 | B2 |
7186262 | Saadat | Mar 2007 | B2 |
7186264 | Liddicoat et al. | Mar 2007 | B2 |
7189199 | McCarthy et al. | Mar 2007 | B2 |
7192443 | Solem et al. | Mar 2007 | B2 |
7220277 | Arru et al. | May 2007 | B2 |
7226467 | Lucatero et al. | Jun 2007 | B2 |
7226477 | Cox | Jun 2007 | B2 |
7226647 | Kasperchik et al. | Jun 2007 | B2 |
7229452 | Kayan | Jun 2007 | B2 |
7238191 | Bachmann | Jul 2007 | B2 |
7288097 | Seguin | Oct 2007 | B2 |
7294148 | McCarthy | Nov 2007 | B2 |
7311728 | Solem et al. | Dec 2007 | B2 |
7311729 | Mathis et al. | Dec 2007 | B2 |
7314485 | Mathis | Jan 2008 | B2 |
7316710 | Cheng et al. | Jan 2008 | B1 |
7329279 | Haug et al. | Feb 2008 | B2 |
7329280 | Bolling et al. | Feb 2008 | B2 |
7335213 | Hyde et al. | Feb 2008 | B1 |
7361190 | Shaoulian et al. | Apr 2008 | B2 |
7364588 | Mathis et al. | Apr 2008 | B2 |
7377941 | Rhee et al. | May 2008 | B2 |
7390329 | Westra et al. | Jun 2008 | B2 |
7404824 | Webler et al. | Jul 2008 | B1 |
7431692 | Zollinger et al. | Oct 2008 | B2 |
7442207 | Rafiee | Oct 2008 | B2 |
7452376 | Lim et al. | Nov 2008 | B2 |
7455690 | Cartledge et al. | Nov 2008 | B2 |
7485142 | Milo | Feb 2009 | B2 |
7485143 | Webler et al. | Feb 2009 | B2 |
7500989 | Solem et al. | Mar 2009 | B2 |
7507252 | Lashinski et al. | Mar 2009 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7510577 | Moaddeb et al. | Mar 2009 | B2 |
7527647 | Spence | May 2009 | B2 |
7530995 | Quijano et al. | May 2009 | B2 |
7549983 | Roue et al. | Jun 2009 | B2 |
7559936 | Levine | Jul 2009 | B2 |
7562660 | Saadat | Jul 2009 | B2 |
7563267 | Goldfarb et al. | Jul 2009 | B2 |
7563273 | Goldfarb et al. | Jul 2009 | B2 |
7569062 | Kuehn et al. | Aug 2009 | B1 |
7585321 | Cribier | Sep 2009 | B2 |
7588582 | Starksen et al. | Sep 2009 | B2 |
7591826 | Alferness et al. | Sep 2009 | B2 |
7604646 | Goldfarb et al. | Oct 2009 | B2 |
7608091 | Goldfarb et al. | Oct 2009 | B2 |
7608103 | McCarthy | Oct 2009 | B2 |
7618449 | Tremulis et al. | Nov 2009 | B2 |
7625403 | Krivoruchko | Dec 2009 | B2 |
7632303 | Stalker et al. | Dec 2009 | B1 |
7635329 | Goldfarb et al. | Dec 2009 | B2 |
7635386 | Gammie | Dec 2009 | B1 |
7655015 | Goldfarb et al. | Feb 2010 | B2 |
7666204 | Thornton et al. | Feb 2010 | B2 |
7682319 | Martin et al. | Mar 2010 | B2 |
7682369 | Seguin | Mar 2010 | B2 |
7686822 | Shayani | Mar 2010 | B2 |
7699892 | Rafiee et al. | Apr 2010 | B2 |
7704269 | St. Goar et al. | Apr 2010 | B2 |
7704277 | Zakay et al. | Apr 2010 | B2 |
7722666 | Lafontaine | May 2010 | B2 |
7736388 | Goldfarb et al. | Jun 2010 | B2 |
7748389 | Salahieh et al. | Jul 2010 | B2 |
7753924 | Starksen et al. | Jul 2010 | B2 |
7758632 | Hojeibane et al. | Jul 2010 | B2 |
7780726 | Seguin | Aug 2010 | B2 |
7871368 | Zollinger et al. | Jan 2011 | B2 |
7871433 | Lattouf | Jan 2011 | B2 |
7883475 | Dupont et al. | Feb 2011 | B2 |
7883538 | To et al. | Feb 2011 | B2 |
7892281 | Seguin et al. | Feb 2011 | B2 |
7927370 | Webler et al. | Apr 2011 | B2 |
7927371 | Navia et al. | Apr 2011 | B2 |
7942927 | Kaye et al. | May 2011 | B2 |
7947056 | Griego et al. | May 2011 | B2 |
7955315 | Feinberg et al. | Jun 2011 | B2 |
7955377 | Melsheimer | Jun 2011 | B2 |
7981152 | Webler et al. | Jul 2011 | B1 |
7992567 | Hirotsuka et al. | Aug 2011 | B2 |
7993368 | Gambale et al. | Aug 2011 | B2 |
7993397 | Lashinski et al. | Aug 2011 | B2 |
8012201 | Lashinski et al. | Sep 2011 | B2 |
8034103 | Burriesci et al. | Oct 2011 | B2 |
8052592 | Goldfarb et al. | Nov 2011 | B2 |
8057493 | Goldfarb et al. | Nov 2011 | B2 |
8062355 | Figulla et al. | Nov 2011 | B2 |
8070804 | Hyde et al. | Dec 2011 | B2 |
8070805 | Vidlund et al. | Dec 2011 | B2 |
8075616 | Solem et al. | Dec 2011 | B2 |
8100964 | Spence | Jan 2012 | B2 |
8123801 | Milo | Feb 2012 | B2 |
8142493 | Spence et al. | Mar 2012 | B2 |
8142495 | Hasenkam et al. | Mar 2012 | B2 |
8142496 | Berreklouw | Mar 2012 | B2 |
8147542 | Maisano et al. | Apr 2012 | B2 |
8152844 | Rao et al. | Apr 2012 | B2 |
8163013 | Machold et al. | Apr 2012 | B2 |
8187299 | Goldfarb et al. | May 2012 | B2 |
8187324 | Webler et al. | May 2012 | B2 |
8202315 | Hlavka et al. | Jun 2012 | B2 |
8206439 | Gomez Duran | Jun 2012 | B2 |
8216302 | Wilson et al. | Jul 2012 | B2 |
8231671 | Kim | Jul 2012 | B2 |
8262725 | Subramanian | Sep 2012 | B2 |
8265758 | Policker et al. | Sep 2012 | B2 |
8277502 | Miller et al. | Oct 2012 | B2 |
8287584 | Salahieh et al. | Oct 2012 | B2 |
8287591 | Keidar et al. | Oct 2012 | B2 |
8292884 | Levine et al. | Oct 2012 | B2 |
8303608 | Goldfarb et al. | Nov 2012 | B2 |
8323334 | Deem et al. | Dec 2012 | B2 |
8328868 | Paul et al. | Dec 2012 | B2 |
8333777 | Schaller et al. | Dec 2012 | B2 |
8343173 | Starksen et al. | Jan 2013 | B2 |
8343174 | Goldfarb et al. | Jan 2013 | B2 |
8343213 | Salahieh et al. | Jan 2013 | B2 |
8349002 | Milo | Jan 2013 | B2 |
8353956 | Miller et al. | Jan 2013 | B2 |
8357195 | Kuehn | Jan 2013 | B2 |
8382829 | Call et al. | Feb 2013 | B1 |
8388680 | Starksen et al. | Mar 2013 | B2 |
8393517 | Milo | Mar 2013 | B2 |
8419825 | Burgler et al. | Apr 2013 | B2 |
8430926 | Kirson | Apr 2013 | B2 |
8449573 | Chu | May 2013 | B2 |
8449599 | Chau et al. | May 2013 | B2 |
8454686 | Alkhatib | Jun 2013 | B2 |
8460370 | Zakay | Jun 2013 | B2 |
8460371 | Hlavka et al. | Jun 2013 | B2 |
8475491 | Miio | Jul 2013 | B2 |
8475525 | Maisano et al. | Jul 2013 | B2 |
8480732 | Subramanian | Jul 2013 | B2 |
8518107 | Tsukashima et al. | Aug 2013 | B2 |
8523940 | Richardson et al. | Sep 2013 | B2 |
8551161 | Dolan | Oct 2013 | B2 |
8585755 | Chau et al. | Nov 2013 | B2 |
8591576 | Hasenkam et al. | Nov 2013 | B2 |
8608797 | Gross et al. | Dec 2013 | B2 |
8628569 | Benichou et al. | Jan 2014 | B2 |
8628571 | Hacohen et al. | Jan 2014 | B1 |
8641727 | Starksen et al. | Feb 2014 | B2 |
8652202 | Alon et al. | Feb 2014 | B2 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8679174 | Ottma et al. | Mar 2014 | B2 |
8685086 | Navia et al. | Apr 2014 | B2 |
8728097 | Sugimoto et al. | May 2014 | B1 |
8728155 | Montorfano et al. | May 2014 | B2 |
8734467 | Miller et al. | May 2014 | B2 |
8734699 | Heideman et al. | May 2014 | B2 |
8740920 | Goldfarb et al. | Jun 2014 | B2 |
8747463 | Fogarty et al. | Jun 2014 | B2 |
8778021 | Cartledge | Jul 2014 | B2 |
8784481 | Alkhatib et al. | Jul 2014 | B2 |
8790367 | Nguyen et al. | Jul 2014 | B2 |
8790394 | Miller et al. | Jul 2014 | B2 |
8795298 | Hernlund et al. | Aug 2014 | B2 |
8795355 | Alkhatib | Aug 2014 | B2 |
8795356 | Quadri et al. | Aug 2014 | B2 |
8795357 | Yohanan et al. | Aug 2014 | B2 |
8808366 | Braido et al. | Aug 2014 | B2 |
8808368 | Maisano et al. | Aug 2014 | B2 |
8845717 | Khairkhahan et al. | Sep 2014 | B2 |
8845723 | Spence et al. | Sep 2014 | B2 |
8852261 | White | Oct 2014 | B2 |
8852272 | Gross et al. | Oct 2014 | B2 |
8858623 | Miller et al. | Oct 2014 | B2 |
8864822 | Spence et al. | Oct 2014 | B2 |
8870948 | Erzberger et al. | Oct 2014 | B1 |
8870949 | Rowe | Oct 2014 | B2 |
8888843 | Khairkhahan et al. | Nov 2014 | B2 |
8889861 | Skead et al. | Nov 2014 | B2 |
8894702 | Quadri et al. | Nov 2014 | B2 |
8911461 | Traynor et al. | Dec 2014 | B2 |
8911494 | Hammer et al. | Dec 2014 | B2 |
8926696 | Cabiri et al. | Jan 2015 | B2 |
8926697 | Gross et al. | Jan 2015 | B2 |
8932343 | Alkhatib et al. | Jan 2015 | B2 |
8932348 | Solem et al. | Jan 2015 | B2 |
8940044 | Hammer et al. | Jan 2015 | B2 |
8945211 | Sugimoto | Feb 2015 | B2 |
8951285 | Sugimoto et al. | Feb 2015 | B2 |
8951286 | Sugimoto et al. | Feb 2015 | B2 |
8961595 | Alkhatib | Feb 2015 | B2 |
8961602 | Kovach et al. | Feb 2015 | B2 |
8979922 | Jayasinghe et al. | Mar 2015 | B2 |
8992604 | Gross et al. | Mar 2015 | B2 |
9005273 | Salahieh et al. | Apr 2015 | B2 |
9011520 | Miller et al. | Apr 2015 | B2 |
9011530 | Reich et al. | Apr 2015 | B2 |
9023100 | Quadri et al. | May 2015 | B2 |
9072603 | Tuval et al. | Jul 2015 | B2 |
9107749 | Bobo et al. | Aug 2015 | B2 |
9119719 | Zipory et al. | Sep 2015 | B2 |
9125632 | Loulmet et al. | Sep 2015 | B2 |
9125742 | Yoganathan et al. | Sep 2015 | B2 |
9138316 | Bielefeld | Sep 2015 | B2 |
9173646 | Fabro | Nov 2015 | B2 |
9180005 | Lashinski et al. | Nov 2015 | B1 |
9180007 | Reich et al. | Nov 2015 | B2 |
9192472 | Gross et al. | Nov 2015 | B2 |
9198756 | Aklog et al. | Dec 2015 | B2 |
9226825 | Starksen et al. | Jan 2016 | B2 |
9265608 | Miller et al. | Feb 2016 | B2 |
9326857 | Cartledge et al. | May 2016 | B2 |
9414921 | Miller et al. | Aug 2016 | B2 |
9427316 | Schweich, Jr. et al. | Aug 2016 | B2 |
9474606 | Zipory et al. | Oct 2016 | B2 |
9526613 | Gross et al. | Dec 2016 | B2 |
9561104 | Miller et al. | Feb 2017 | B2 |
9579090 | Simms et al. | Feb 2017 | B1 |
9693865 | Gilmore et al. | Jul 2017 | B2 |
9730793 | Reich et al. | Aug 2017 | B2 |
9788941 | Hacohen | Oct 2017 | B2 |
9801720 | Gilmore et al. | Oct 2017 | B2 |
9907547 | Gilmore et al. | Mar 2018 | B2 |
10368852 | Gerhardt et al. | Aug 2019 | B2 |
20010021874 | Carpentier et al. | Sep 2001 | A1 |
20020022862 | Grafton et al. | Feb 2002 | A1 |
20020082525 | Oslund et al. | Jun 2002 | A1 |
20020087048 | Brock et al. | Jul 2002 | A1 |
20020103532 | Langberg et al. | Aug 2002 | A1 |
20020120292 | Morgan | Aug 2002 | A1 |
20020151916 | Muramatsu et al. | Oct 2002 | A1 |
20020151970 | Garrison et al. | Oct 2002 | A1 |
20020169358 | Mortier et al. | Nov 2002 | A1 |
20020177904 | Huxel et al. | Nov 2002 | A1 |
20020188301 | Dallara et al. | Dec 2002 | A1 |
20020188350 | Arru et al. | Dec 2002 | A1 |
20020198586 | Inoue | Dec 2002 | A1 |
20030050693 | Quijano et al. | Mar 2003 | A1 |
20030078465 | Pai et al. | Apr 2003 | A1 |
20030078653 | Vesely et al. | Apr 2003 | A1 |
20030105519 | Fasol et al. | Jun 2003 | A1 |
20030114901 | Loeb et al. | Jun 2003 | A1 |
20030120340 | Liska et al. | Jun 2003 | A1 |
20030144657 | Bowe et al. | Jul 2003 | A1 |
20030171760 | Gambale | Sep 2003 | A1 |
20030199974 | Lee et al. | Oct 2003 | A1 |
20030204193 | Gabriel et al. | Oct 2003 | A1 |
20030204195 | Keane et al. | Oct 2003 | A1 |
20030229350 | Kay | Dec 2003 | A1 |
20030229395 | Cox | Dec 2003 | A1 |
20040002735 | Lizardi et al. | Jan 2004 | A1 |
20040010287 | Bonutti | Jan 2004 | A1 |
20040019359 | Worley et al. | Jan 2004 | A1 |
20040019377 | Taylor et al. | Jan 2004 | A1 |
20040024451 | Johnson et al. | Feb 2004 | A1 |
20040039442 | St. Goar et al. | Feb 2004 | A1 |
20040044350 | Martin et al. | Mar 2004 | A1 |
20040059413 | Argento | Mar 2004 | A1 |
20040068273 | Fariss et al. | Apr 2004 | A1 |
20040111095 | Gordon et al. | Jun 2004 | A1 |
20040122514 | Fogarty et al. | Jun 2004 | A1 |
20040127982 | Machold et al. | Jul 2004 | A1 |
20040133274 | Webler et al. | Jul 2004 | A1 |
20040133374 | Kattan | Jul 2004 | A1 |
20040138744 | Lashinski et al. | Jul 2004 | A1 |
20040138745 | Macoviak et al. | Jul 2004 | A1 |
20040148019 | Vidlund et al. | Jul 2004 | A1 |
20040148020 | Vidlund et al. | Jul 2004 | A1 |
20040148021 | Cartledge et al. | Jul 2004 | A1 |
20040176788 | Opolski | Sep 2004 | A1 |
20040181287 | Gellman | Sep 2004 | A1 |
20040186566 | Hindrichs et al. | Sep 2004 | A1 |
20040193191 | Starksen et al. | Sep 2004 | A1 |
20040243227 | Starksen et al. | Dec 2004 | A1 |
20040260317 | Bloom et al. | Dec 2004 | A1 |
20040260344 | Lyons et al. | Dec 2004 | A1 |
20040260393 | Rahdert et al. | Dec 2004 | A1 |
20040260394 | Douk et al. | Dec 2004 | A1 |
20040267358 | Reitan | Dec 2004 | A1 |
20050004668 | Aklog et al. | Jan 2005 | A1 |
20050010287 | Macoviak et al. | Jan 2005 | A1 |
20050010787 | Tarbouriech | Jan 2005 | A1 |
20050016560 | Voughlohn | Jan 2005 | A1 |
20050049692 | Numamoto et al. | Mar 2005 | A1 |
20050055038 | Kelleher et al. | Mar 2005 | A1 |
20050055087 | Starksen | Mar 2005 | A1 |
20050060030 | Lashinski et al. | Mar 2005 | A1 |
20050065601 | Lee et al. | Mar 2005 | A1 |
20050070999 | Spence | Mar 2005 | A1 |
20050075727 | Wheatley | Apr 2005 | A1 |
20050090827 | Gedebou | Apr 2005 | A1 |
20050090834 | Chiang et al. | Apr 2005 | A1 |
20050096740 | Langberg et al. | May 2005 | A1 |
20050107871 | Realyvasquez et al. | May 2005 | A1 |
20050119734 | Spence et al. | Jun 2005 | A1 |
20050125002 | Baran et al. | Jun 2005 | A1 |
20050125011 | Spence et al. | Jun 2005 | A1 |
20050131533 | Alfieri et al. | Jun 2005 | A1 |
20050137686 | Salahieh et al. | Jun 2005 | A1 |
20050137688 | Salahieh et al. | Jun 2005 | A1 |
20050137695 | Salahieh et al. | Jun 2005 | A1 |
20050159728 | Armour et al. | Jul 2005 | A1 |
20050159810 | Filsoufi | Jul 2005 | A1 |
20050171601 | Cosgrove et al. | Aug 2005 | A1 |
20050177180 | Kaganov et al. | Aug 2005 | A1 |
20050177228 | Solem et al. | Aug 2005 | A1 |
20050187568 | Klenk et al. | Aug 2005 | A1 |
20050192596 | Jugenheimer et al. | Sep 2005 | A1 |
20050203549 | Realyvasquez | Sep 2005 | A1 |
20050203606 | VanCamp | Sep 2005 | A1 |
20050216039 | Lederman | Sep 2005 | A1 |
20050216079 | MaCoviak | Sep 2005 | A1 |
20050222665 | Aranyi | Oct 2005 | A1 |
20050234481 | Waller | Oct 2005 | A1 |
20050240199 | Martinek et al. | Oct 2005 | A1 |
20050256532 | Nayak et al. | Nov 2005 | A1 |
20050267478 | Corradi et al. | Dec 2005 | A1 |
20050273138 | To et al. | Dec 2005 | A1 |
20050288778 | Shaoulian et al. | Dec 2005 | A1 |
20060004442 | Spenser et al. | Jan 2006 | A1 |
20060004443 | Liddicoat et al. | Jan 2006 | A1 |
20060020326 | Bolduc et al. | Jan 2006 | A9 |
20060020327 | Lashinski et al. | Jan 2006 | A1 |
20060020333 | Lashinski et al. | Jan 2006 | A1 |
20060020336 | Liddicoat | Jan 2006 | A1 |
20060025787 | Morales et al. | Feb 2006 | A1 |
20060025858 | Alameddine | Feb 2006 | A1 |
20060030885 | Hyde | Feb 2006 | A1 |
20060041319 | Taylor et al. | Feb 2006 | A1 |
20060069429 | Spence et al. | Mar 2006 | A1 |
20060074486 | Liddicoat et al. | Apr 2006 | A1 |
20060085012 | Dolan | Apr 2006 | A1 |
20060095009 | Lampropoulos et al. | May 2006 | A1 |
20060106423 | Weisel et al. | May 2006 | A1 |
20060116757 | Lashinski et al. | Jun 2006 | A1 |
20060122633 | To et al. | Jun 2006 | A1 |
20060129166 | Lavelle | Jun 2006 | A1 |
20060142694 | Bednarek et al. | Jun 2006 | A1 |
20060149280 | Harvie et al. | Jul 2006 | A1 |
20060149368 | Spence | Jul 2006 | A1 |
20060161265 | Levine et al. | Jul 2006 | A1 |
20060184240 | Jimenez et al. | Aug 2006 | A1 |
20060184242 | Lichtenstein | Aug 2006 | A1 |
20060195134 | Crittenden | Aug 2006 | A1 |
20060206203 | Yang et al. | Sep 2006 | A1 |
20060241622 | Zergiebel | Oct 2006 | A1 |
20060241656 | Starksen et al. | Oct 2006 | A1 |
20060241748 | Lee et al. | Oct 2006 | A1 |
20060247763 | Slater | Nov 2006 | A1 |
20060259135 | Navia et al. | Nov 2006 | A1 |
20060271175 | Woolfson et al. | Nov 2006 | A1 |
20060276871 | Lamson et al. | Dec 2006 | A1 |
20060282161 | Huynh et al. | Dec 2006 | A1 |
20060287661 | Bolduc et al. | Dec 2006 | A1 |
20060287716 | Banbury et al. | Dec 2006 | A1 |
20070001627 | Lin et al. | Jan 2007 | A1 |
20070010800 | Weitzner et al. | Jan 2007 | A1 |
20070016287 | Cartledge et al. | Jan 2007 | A1 |
20070016288 | Gurskis et al. | Jan 2007 | A1 |
20070021781 | Jervis et al. | Jan 2007 | A1 |
20070027533 | Douk | Feb 2007 | A1 |
20070027536 | Mihaljevic et al. | Feb 2007 | A1 |
20070032823 | Tegg | Feb 2007 | A1 |
20070038221 | Fine et al. | Feb 2007 | A1 |
20070038293 | St.Goar et al. | Feb 2007 | A1 |
20070038296 | Navia et al. | Feb 2007 | A1 |
20070039425 | Wang | Feb 2007 | A1 |
20070049942 | Hindrichs et al. | Mar 2007 | A1 |
20070049970 | Belef et al. | Mar 2007 | A1 |
20070051377 | Douk et al. | Mar 2007 | A1 |
20070055206 | To et al. | Mar 2007 | A1 |
20070061010 | Hauser et al. | Mar 2007 | A1 |
20070066863 | Rafiee et al. | Mar 2007 | A1 |
20070078297 | Rafiee et al. | Apr 2007 | A1 |
20070080188 | Spence et al. | Apr 2007 | A1 |
20070083168 | Whiting et al. | Apr 2007 | A1 |
20070083235 | Jervis et al. | Apr 2007 | A1 |
20070100427 | Perouse | May 2007 | A1 |
20070106328 | Wardle et al. | May 2007 | A1 |
20070112359 | Kimura et al. | May 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070118151 | Davidson | May 2007 | A1 |
20070118154 | Crabtree | May 2007 | A1 |
20070118213 | Loulmet | May 2007 | A1 |
20070118215 | Moaddeb | May 2007 | A1 |
20070142907 | Moaddeb et al. | Jun 2007 | A1 |
20070162111 | Fukamachi et al. | Jul 2007 | A1 |
20070173931 | Tremulis et al. | Jul 2007 | A1 |
20070198082 | Kapadia et al. | Aug 2007 | A1 |
20070219558 | Deutsch | Sep 2007 | A1 |
20070239208 | Crawford | Oct 2007 | A1 |
20070244554 | Rafiee et al. | Oct 2007 | A1 |
20070244556 | Rafiee et al. | Oct 2007 | A1 |
20070255397 | Ryan et al. | Nov 2007 | A1 |
20070255400 | Parravicini et al. | Nov 2007 | A1 |
20070270755 | Von Oepen et al. | Nov 2007 | A1 |
20070276437 | Call et al. | Nov 2007 | A1 |
20070282375 | Hindrichs et al. | Dec 2007 | A1 |
20070282429 | Hauser et al. | Dec 2007 | A1 |
20070295172 | Swartz | Dec 2007 | A1 |
20070299424 | Cumming et al. | Dec 2007 | A1 |
20080004697 | Lichtenstein et al. | Jan 2008 | A1 |
20080027483 | Cartledge et al. | Jan 2008 | A1 |
20080027555 | Hawkins | Jan 2008 | A1 |
20080035160 | Woodson et al. | Feb 2008 | A1 |
20080039935 | Buch et al. | Feb 2008 | A1 |
20080051703 | Thornton et al. | Feb 2008 | A1 |
20080058595 | Snoke et al. | Mar 2008 | A1 |
20080065011 | Marchand et al. | Mar 2008 | A1 |
20080065204 | Macoviak et al. | Mar 2008 | A1 |
20080071366 | Tuval et al. | Mar 2008 | A1 |
20080086138 | Stone et al. | Apr 2008 | A1 |
20080086203 | Roberts | Apr 2008 | A1 |
20080091169 | Heideman et al. | Apr 2008 | A1 |
20080091257 | Andreas et al. | Apr 2008 | A1 |
20080097483 | Ortiz et al. | Apr 2008 | A1 |
20080097523 | Bolduc et al. | Apr 2008 | A1 |
20080103572 | Gerber | May 2008 | A1 |
20080140116 | Bonutti | Jun 2008 | A1 |
20080167713 | Bolling | Jul 2008 | A1 |
20080167714 | St. Goar et al. | Jul 2008 | A1 |
20080177380 | Starksen et al. | Jul 2008 | A1 |
20080195126 | Solem | Aug 2008 | A1 |
20080195200 | Vidlund et al. | Aug 2008 | A1 |
20080208265 | Frazier et al. | Aug 2008 | A1 |
20080221672 | Lamphere et al. | Sep 2008 | A1 |
20080228030 | Godin | Sep 2008 | A1 |
20080234729 | Page et al. | Sep 2008 | A1 |
20080262480 | Stabler et al. | Oct 2008 | A1 |
20080262609 | Gross et al. | Oct 2008 | A1 |
20080275300 | Rothe et al. | Nov 2008 | A1 |
20080275469 | Fanton et al. | Nov 2008 | A1 |
20080275551 | Alfieri | Nov 2008 | A1 |
20080281353 | Aranyi et al. | Nov 2008 | A1 |
20080281411 | Berreklouw | Nov 2008 | A1 |
20080287862 | Weitzner et al. | Nov 2008 | A1 |
20080288044 | Osborne | Nov 2008 | A1 |
20080288062 | Andrieu et al. | Nov 2008 | A1 |
20080294251 | Annest et al. | Nov 2008 | A1 |
20080300537 | Bowman | Dec 2008 | A1 |
20080300629 | Surti | Dec 2008 | A1 |
20080312506 | Spivey et al. | Dec 2008 | A1 |
20090024110 | Heideman et al. | Jan 2009 | A1 |
20090028670 | Garcia et al. | Jan 2009 | A1 |
20090043381 | Macoviak et al. | Feb 2009 | A1 |
20090054723 | Khairkhahan et al. | Feb 2009 | A1 |
20090054969 | Salahieh et al. | Feb 2009 | A1 |
20090062866 | Jackson | Mar 2009 | A1 |
20090076586 | Hauser et al. | Mar 2009 | A1 |
20090076600 | Quinn | Mar 2009 | A1 |
20090082797 | Fung et al. | Mar 2009 | A1 |
20090088837 | Gillinov et al. | Apr 2009 | A1 |
20090093877 | Keidar et al. | Apr 2009 | A1 |
20090099650 | Bolduc et al. | Apr 2009 | A1 |
20090105816 | Olsen et al. | Apr 2009 | A1 |
20090125102 | Cartledge et al. | May 2009 | A1 |
20090166913 | Guo et al. | Jul 2009 | A1 |
20090171439 | Nissl | Jul 2009 | A1 |
20090177266 | Powell et al. | Jul 2009 | A1 |
20090177274 | Scorsin et al. | Jul 2009 | A1 |
20090248148 | Shaolian et al. | Oct 2009 | A1 |
20090254103 | Deutsch | Oct 2009 | A1 |
20090264994 | Saadat | Oct 2009 | A1 |
20090287231 | Brooks et al. | Nov 2009 | A1 |
20090287304 | Dahlgren et al. | Nov 2009 | A1 |
20090299409 | Coe et al. | Dec 2009 | A1 |
20090326648 | Machold et al. | Dec 2009 | A1 |
20100001038 | Levin et al. | Jan 2010 | A1 |
20100010538 | Juravic et al. | Jan 2010 | A1 |
20100023118 | Medlock et al. | Jan 2010 | A1 |
20100030014 | Ferrazzi | Feb 2010 | A1 |
20100030328 | Seguin et al. | Feb 2010 | A1 |
20100042147 | Janovsky et al. | Feb 2010 | A1 |
20100049213 | Serina et al. | Feb 2010 | A1 |
20100063542 | van der Burg et al. | Mar 2010 | A1 |
20100063550 | Felix et al. | Mar 2010 | A1 |
20100076499 | McNamara et al. | Mar 2010 | A1 |
20100094248 | Nguyen et al. | Apr 2010 | A1 |
20100094314 | Hernlund et al. | Apr 2010 | A1 |
20100106141 | Osypka et al. | Apr 2010 | A1 |
20100114180 | Rock et al. | May 2010 | A1 |
20100121349 | Meier et al. | May 2010 | A1 |
20100121435 | Subramanian et al. | May 2010 | A1 |
20100121437 | Subramanian et al. | May 2010 | A1 |
20100130989 | Bourque et al. | May 2010 | A1 |
20100130992 | Machold et al. | May 2010 | A1 |
20100152845 | Bloom et al. | Jun 2010 | A1 |
20100161043 | Maisano et al. | Jun 2010 | A1 |
20100168845 | Wright | Jul 2010 | A1 |
20100174358 | Rabkin et al. | Jul 2010 | A1 |
20100179574 | Longoria et al. | Jul 2010 | A1 |
20100217184 | Koblish et al. | Aug 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100234935 | Bashiri et al. | Sep 2010 | A1 |
20100249497 | Peine et al. | Sep 2010 | A1 |
20100249908 | Chau et al. | Sep 2010 | A1 |
20100249915 | Zhang | Sep 2010 | A1 |
20100249920 | Bolling et al. | Sep 2010 | A1 |
20100262232 | Annest | Oct 2010 | A1 |
20100262233 | He | Oct 2010 | A1 |
20100286628 | Gross | Nov 2010 | A1 |
20100298929 | Thornton et al. | Nov 2010 | A1 |
20100305475 | Hinchliffe et al. | Dec 2010 | A1 |
20100324598 | Anderson | Dec 2010 | A1 |
20110004210 | Johnson et al. | Jan 2011 | A1 |
20110004298 | Lee et al. | Jan 2011 | A1 |
20110009956 | Cartledge et al. | Jan 2011 | A1 |
20110011917 | Loulmet | Jan 2011 | A1 |
20110026208 | Utsuro et al. | Feb 2011 | A1 |
20110029066 | Gilad et al. | Feb 2011 | A1 |
20110035000 | Nieminen et al. | Feb 2011 | A1 |
20110066231 | Cartledge et al. | Mar 2011 | A1 |
20110067770 | Pederson et al. | Mar 2011 | A1 |
20110071626 | Wright et al. | Mar 2011 | A1 |
20110082538 | Dahlgren et al. | Apr 2011 | A1 |
20110087146 | Ryan et al. | Apr 2011 | A1 |
20110093002 | Rucker et al. | Apr 2011 | A1 |
20110118832 | Punjabi | May 2011 | A1 |
20110137410 | Hacohen | Jun 2011 | A1 |
20110144703 | Krause et al. | Jun 2011 | A1 |
20110202130 | Cartledge et al. | Aug 2011 | A1 |
20110208283 | Rust | Aug 2011 | A1 |
20110230941 | Markus | Sep 2011 | A1 |
20110230961 | Langer et al. | Sep 2011 | A1 |
20110238088 | Bolduc et al. | Sep 2011 | A1 |
20110257433 | Walker | Oct 2011 | A1 |
20110257633 | Cartledge et al. | Oct 2011 | A1 |
20110264208 | Duffy et al. | Oct 2011 | A1 |
20110276062 | Bolduc | Nov 2011 | A1 |
20110288435 | Christy et al. | Nov 2011 | A1 |
20110301498 | Maenhout et al. | Dec 2011 | A1 |
20120053628 | Sojka et al. | Mar 2012 | A1 |
20120065464 | Ellis et al. | Mar 2012 | A1 |
20120078355 | Zipory et al. | Mar 2012 | A1 |
20120078359 | Li et al. | Mar 2012 | A1 |
20120089022 | House et al. | Apr 2012 | A1 |
20120089125 | Scheibe et al. | Apr 2012 | A1 |
20120095552 | Spence et al. | Apr 2012 | A1 |
20120109155 | Robinson et al. | May 2012 | A1 |
20120150290 | Gabbay | Jun 2012 | A1 |
20120158021 | Morrill | Jun 2012 | A1 |
20120158023 | Mitelberg et al. | Jun 2012 | A1 |
20120179086 | Shank et al. | Jul 2012 | A1 |
20120191182 | Hauser et al. | Jul 2012 | A1 |
20120226349 | Tuval et al. | Sep 2012 | A1 |
20120239142 | Liu et al. | Sep 2012 | A1 |
20120245604 | Tegzes | Sep 2012 | A1 |
20120271198 | Whittaker et al. | Oct 2012 | A1 |
20120296349 | Smith et al. | Nov 2012 | A1 |
20120296417 | Hill et al. | Nov 2012 | A1 |
20120310330 | Buchbinder et al. | Dec 2012 | A1 |
20120323313 | Seguin | Dec 2012 | A1 |
20130030522 | Rowe et al. | Jan 2013 | A1 |
20130046373 | Cartledge et al. | Feb 2013 | A1 |
20130053884 | Roorda | Feb 2013 | A1 |
20130079873 | Migliazza et al. | Mar 2013 | A1 |
20130085529 | Housman | Apr 2013 | A1 |
20130090724 | Subramanian et al. | Apr 2013 | A1 |
20130096673 | Hill et al. | Apr 2013 | A1 |
20130116776 | Gross et al. | May 2013 | A1 |
20130123910 | Cartledge et al. | May 2013 | A1 |
20130131791 | Hlavka et al. | May 2013 | A1 |
20130166017 | Cartledge et al. | Jun 2013 | A1 |
20130190863 | Call et al. | Jul 2013 | A1 |
20130204361 | Adams et al. | Aug 2013 | A1 |
20130226289 | Shaolian et al. | Aug 2013 | A1 |
20130226290 | Yellin et al. | Aug 2013 | A1 |
20130231701 | Voss et al. | Sep 2013 | A1 |
20130268069 | Zakai et al. | Oct 2013 | A1 |
20130282059 | Ketai et al. | Oct 2013 | A1 |
20130289718 | Tsukashima et al. | Oct 2013 | A1 |
20130297013 | Klima et al. | Nov 2013 | A1 |
20130304093 | Serina et al. | Nov 2013 | A1 |
20130331930 | Rowe et al. | Dec 2013 | A1 |
20140067054 | Chau et al. | Mar 2014 | A1 |
20140081394 | Keranen et al. | Mar 2014 | A1 |
20140088368 | Park | Mar 2014 | A1 |
20140088646 | Wales et al. | Mar 2014 | A1 |
20140094826 | Sutherland et al. | Apr 2014 | A1 |
20140094903 | Miller et al. | Apr 2014 | A1 |
20140094906 | Spence et al. | Apr 2014 | A1 |
20140114390 | Tobis et al. | Apr 2014 | A1 |
20140135799 | Henderson | May 2014 | A1 |
20140142619 | Serina et al. | May 2014 | A1 |
20140142695 | Gross et al. | May 2014 | A1 |
20140148849 | Serina et al. | May 2014 | A1 |
20140155783 | Starksen et al. | Jun 2014 | A1 |
20140163670 | Alon et al. | Jun 2014 | A1 |
20140163690 | White | Jun 2014 | A1 |
20140188108 | Goodine et al. | Jul 2014 | A1 |
20140188140 | Meier et al. | Jul 2014 | A1 |
20140188215 | Hlavka et al. | Jul 2014 | A1 |
20140194976 | Starksen et al. | Jul 2014 | A1 |
20140207231 | Hacohen et al. | Jul 2014 | A1 |
20140243859 | Robinson | Aug 2014 | A1 |
20140243894 | Groothuis et al. | Aug 2014 | A1 |
20140243963 | Sheps et al. | Aug 2014 | A1 |
20140251042 | Asselin et al. | Sep 2014 | A1 |
20140275757 | Goodwin et al. | Sep 2014 | A1 |
20140276648 | Hammer et al. | Sep 2014 | A1 |
20140296962 | Cartledge et al. | Oct 2014 | A1 |
20140303649 | Nguyen et al. | Oct 2014 | A1 |
20140303720 | Sugimoto et al. | Oct 2014 | A1 |
20140309661 | Sheps et al. | Oct 2014 | A1 |
20140309730 | Alon et al. | Oct 2014 | A1 |
20140343668 | Zipory et al. | Nov 2014 | A1 |
20140350660 | Cocks et al. | Nov 2014 | A1 |
20140379006 | Sutherland et al. | Dec 2014 | A1 |
20150018940 | Quill et al. | Jan 2015 | A1 |
20150051697 | Spence et al. | Feb 2015 | A1 |
20150081014 | Gross et al. | Mar 2015 | A1 |
20150094800 | Chawla | Apr 2015 | A1 |
20150100116 | Mohl et al. | Apr 2015 | A1 |
20150112432 | Reich et al. | Apr 2015 | A1 |
20150127097 | Neumann et al. | May 2015 | A1 |
20150133997 | Deitch et al. | May 2015 | A1 |
20150182336 | Zipory et al. | Jul 2015 | A1 |
20150230919 | Chau et al. | Aug 2015 | A1 |
20150272586 | Herman et al. | Oct 2015 | A1 |
20150272734 | Sheps et al. | Oct 2015 | A1 |
20150282931 | Brunnett et al. | Oct 2015 | A1 |
20150351910 | Gilmore et al. | Dec 2015 | A1 |
20160008132 | Cabiri et al. | Jan 2016 | A1 |
20160029920 | Kronstrom et al. | Feb 2016 | A1 |
20160058557 | Reich et al. | Mar 2016 | A1 |
20160113767 | Miller et al. | Apr 2016 | A1 |
20160120642 | Shaolian et al. | May 2016 | A1 |
20160120645 | Alon | May 2016 | A1 |
20160158008 | Miller et al. | Jun 2016 | A1 |
20160242762 | Gilmore et al. | Aug 2016 | A1 |
20160262755 | Zipory et al. | Sep 2016 | A1 |
20160302917 | Schewel | Oct 2016 | A1 |
20160317302 | Madjarov et al. | Nov 2016 | A1 |
20160361058 | Bolduc et al. | Dec 2016 | A1 |
20160361168 | Gross et al. | Dec 2016 | A1 |
20160361169 | Gross et al. | Dec 2016 | A1 |
20170000609 | Gross et al. | Jan 2017 | A1 |
20170042670 | Shaolian et al. | Feb 2017 | A1 |
20170100119 | Baird et al. | Apr 2017 | A1 |
20170224489 | Starksen et al. | Aug 2017 | A1 |
20170245993 | Gross et al. | Aug 2017 | A1 |
20180008409 | Kutzik et al. | Jan 2018 | A1 |
20180049875 | Iflah et al. | Feb 2018 | A1 |
20180140420 | Hayoz et al. | May 2018 | A1 |
20180168803 | Pesce et al. | Jun 2018 | A1 |
20180228608 | Sheps et al. | Aug 2018 | A1 |
20180256334 | Sheps et al. | Sep 2018 | A1 |
20180289480 | D'ambra et al. | Oct 2018 | A1 |
20180318080 | Quill et al. | Nov 2018 | A1 |
20180318083 | Bolling et al. | Nov 2018 | A1 |
20190029498 | Mankowski et al. | Jan 2019 | A1 |
20190038411 | Alon | Feb 2019 | A1 |
20190111239 | Bolduc et al. | Apr 2019 | A1 |
20190117400 | Medema et al. | Apr 2019 | A1 |
20190125325 | Sheps et al. | May 2019 | A1 |
20190151093 | Keidar et al. | May 2019 | A1 |
20190175344 | Khairkhahan | Jun 2019 | A1 |
20190175345 | Schaffner et al. | Jun 2019 | A1 |
20190175346 | Schaffner et al. | Jun 2019 | A1 |
20190183648 | Trapp et al. | Jun 2019 | A1 |
20190240023 | Spence et al. | Aug 2019 | A1 |
20190290260 | Caffes et al. | Sep 2019 | A1 |
20190290431 | Genovese et al. | Sep 2019 | A1 |
20190321049 | Herman et al. | Oct 2019 | A1 |
20190343633 | Garvin et al. | Nov 2019 | A1 |
20200015971 | Brauon et al. | Jan 2020 | A1 |
20200085577 | Vola | Mar 2020 | A1 |
20200289267 | Peleg et al. | Sep 2020 | A1 |
20200337840 | Reich | Oct 2020 | A1 |
20210015475 | Lau | Jan 2021 | A1 |
20210059820 | Clark et al. | Mar 2021 | A1 |
20210085461 | Neumark et al. | Mar 2021 | A1 |
20210093453 | Peleg et al. | Apr 2021 | A1 |
20220096232 | Skaro et al. | Mar 2022 | A1 |
Number | Date | Country |
---|---|---|
113331995 | Sep 2021 | CN |
1034753 | Sep 2000 | EP |
3531975 | Sep 2019 | EP |
9205093 | Apr 1992 | WO |
9846149 | Oct 1998 | WO |
02085250 | Feb 2003 | WO |
03047467 | Jun 2003 | WO |
2010000454 | Jan 2010 | WO |
2012176195 | Mar 2013 | WO |
2014064964 | May 2014 | WO |
2019145941 | Aug 2019 | WO |
2019145947 | Aug 2019 | WO |
2019182645 | Sep 2019 | WO |
2019224814 | Nov 2019 | WO |
2020240282 | Dec 2020 | WO |
2021014440 | Jan 2021 | WO |
2021038559 | Mar 2021 | WO |
2021038560 | Mar 2021 | WO |
Entry |
---|
Agarwal et al. International Cardiology Perspective Functional Tricuspid Regurgitation, Circ Cardiovasc Interv 2009;2;2;565-573 (2009). |
Ahmadi, A., G. Spillner, and Th Johannessen. “Hemodynamic changes following experimental production and correction of acute mitral regurgitation with an adjustable ring prosthesis.” The Thoracic and cardiovascular surgeon36.06 (1988): 313-319. |
Ahmadi, Ali et al. “Percutaneousiy adjustable pulmonary artery band.” The Annals of thoracic surgery 60 (1995): S520-S522. |
Alfieri et al.“Novel Suture Device for Beating-Heart Mitral Leaflet Approximation”, Ann Thorac Surg. 2002, 74:1488-1493. |
Alfieri et al., “An effective technique to correct anterior mitral leaflet prolapse,” J Card 14(6):468-470 (1999). |
Alfieri et al., “The double orifice technique in mitral valve repair: a simple solution for complex problems,” Journal of Thoracic Cardiovascular Surgery 122:674-681 (2001). |
Alfieri, “The edge-to-edge repair of the mitral valve,” [Abstract] 6th Annual NewEra Cardiac Care: Innovation & Technology, Heart Surgery Forum pp. 103. (2000). |
Amplatzer Cardiac Plug brochure (English pages), AGA Medical Corporation (Plymouth, MN) (copyright 2008-2010, downloaded Jan. 11, 2011). |
Amplatzer® Cribriform Occluder. A patient guide to Percutaneous, Transcatheter, Atrial Septal Defect Closuer, AGA Medical Corporation, Apr. 2008. |
Amplatzer® Septal Occluder. A patient guide to the Non-Surgicai Closuer of the Atrial Septal Defect Using the Amplatzer Septal Occluder System, AGA Medical Corporation, Apr. 2008. |
Assad, Renato S. “Adjustable Pulmonary Artery Banding.” (2014). |
Brennan, Jennifer, 510(k) Summary of safety and effectiveness, Jan. 2008. |
Daebritz, S. et al. “Experience with an adjustable pulmonary artery banding device in two cases: initial success-midterm failure.” The Thoracic and cardiovascular surgeon 47.01 (1999): 51-52. |
Dang NC et al. “Simplified Placement of Multiple Artificial Mitral Valve Chords,” The Heart Surgery Forum #2005-1005, 8 (3) (2005). |
Dictionary.com definition of “lock”, Jul. 29, 2013. |
Dieter RS, “Percutaneous valve repair: Update on mitral regurgitation and endovascular approaches to the mitral valve,” Applications in Imaging, Cardiac Interventions, Supported by an educational grant from Amersham Health pp. 11-14 (2003). |
Elliott, Daniel S., Gerald W. Timm, and David M. Barrett. “An implantable mechanical urinary sphincter: a new nonhydraulic design concept.” Urology52.6 (1998): 1151-1154. |
Langer et al. Ring plus String: Papillary muscle repositioning as an adjunctive repair technique for ischemic mitral regurgitation, The Journal of Thoracic Cardiovascular surgery vol. 133 No. 1, Jan. 2007. |
Langer et al. Ring+String, Successful Repair technique for ischemic mitral regurgitation with severe leaflet Tethering, The Department of Thoracic Cardiovascular surgery, Hamburg, Germany, Nov. 2008. |
Maisano, “The double-orifice technique as a standardized approach to treat mitral,” European Journal of Cardio-thoracic Surgery 17 (2000) 201-205. |
O'Reilly S et al., “Heart valve surgery pushes the envelope,” Medtech Insight 8(3): 73, 99-108 (2006). |
Odell JA et al., “Early Results o4yf a Simplified Method of Mitral Valve Annuloplasty,” Circulation 92:150-154 (1995). |
Park, Sang C. et al. “A percutaneousiy adjustable device for banding of the pulmonary trunk.” International journal of cardiology 9.4 (1985): 477-484. |
Swain CP et al., “An endoscopically deliverable tissue-transfixing device for securing biosensors in the gastrointestinal tract,” Gastrointestinal Endoscopy 40(6): 730-734 (1994). |
Swenson, O. An experimental implantable urinary sphincter. Invest Urol. Sep. 1976;14(2):100-3. |
Swenson, O. and Malinin, T.I., 1978. An improved mechanical device for control of urinary incontinence. Investigative urology, 15(5), pp. 389-391. |
Swenson, Orvar. “Internal device for control of urinary incontinence.” Journal of pediatric surgery 7.5 (1972): 542-545. |
Tajik, Abdul, “Two dimensional real-time ultrasonic imaging of the heart and great vessels”, Mayo Clin Proc. vol. 53:271-303, 1978. |
Number | Date | Country | |
---|---|---|---|
20200337840 A1 | Oct 2020 | US |
Number | Date | Country | |
---|---|---|---|
62622315 | Jan 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/IL2019/050083 | Jan 2019 | US |
Child | 16926580 | US |